Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsMaria Ferrara, MD
Assistant Professor Adjunct of PsychiatryAbout
Research
Publications
2026
Impact of genetic variants on hippocampal volume among individuals with schizophrenia and bipolar disorders
Toffanin T, Perini G, Follador H, Zonta F, Ferri G, Pigato G, Pagano M, Scupola N, Pinato C, Calosci D, Ferrara M, Muscettola A, De Bellis G, Montemitro C, Zerbinati L, Nanni M, Caruso R, Escelsior A, Baratto A, Martino N, Trevisson E, Olivo D, Sambataro F, Grassi L, Murri M. Impact of genetic variants on hippocampal volume among individuals with schizophrenia and bipolar disorders. Psychiatry Research Neuroimaging 2026, 357: 112147. PMID: 41570363, DOI: 10.1016/j.pscychresns.2026.112147.Peer-Reviewed Original ResearchConceptsHippocampal volumeBP-IBipolar disorder type IMarker of schizophreniaHippocampal volume reductionAssociated with lower hippocampal volumeLower hippocampal volumeGenetic variantsPsychosis vulnerabilityImpact of genetic variantsBipolar disorderRightward asymmetryHippocampal morphologySchizophreniaAA genotypeHippocampal atrophyHippocampalMean volumeMultilevel modelsT MRIDISC1COMTGenetic factorsBayesian multilevel modelsVolume reductionSex differences in the prescription of long-acting antipsychotics: results from a retrospective study
Ferrara M, Domenicano I, Onofrio A, Marchi A, Zaffarami G, Gentili E, Benini L, Grassi L. Sex differences in the prescription of long-acting antipsychotics: results from a retrospective study. Neuroscience Applied 2026, 5: 105743. DOI: 10.1016/j.nsa.2025.105743.Peer-Reviewed Original Research
2025
Sex differences in outcomes of first episode psychosis: results from an early intervention service
Domenicano I, Onofrio A, Citton M, Vecchioni L, De Donatis D, Bertelli R, Emanuelli F, Grassi L, Ferrara M. Sex differences in outcomes of first episode psychosis: results from an early intervention service. Frontiers In Behavioral Neuroscience 2025, 19: 1642460. PMID: 40989499, PMCID: PMC12450961, DOI: 10.3389/fnbeh.2025.1642460.Peer-Reviewed Original ResearchFirst-episode psychosisEarly intervention servicesSex differencesRates of cannabis useIntervention servicesAbsence of intellectual disabilityNon-affective psychosisPsychotic disordersEpisode psychosisCannabis useIntellectual disabilityOrganic psychosisPsychosisAlcohol misuseFollow-upProgram admissionOutcomes of patientsClinical trajectoryLong-term prognosisClinical perspectiveLong follow-upMonths follow-upMeasures analysisSex-based differencesMixed effects modelsThe association between cannabis use and paranoia: Meta-analysis of experimental and observational studies
Belvederi Murri M, Catania S, Centra S, Folesani F, Muscettola A, Zerbinati L, Toffanin T, Ferrara M, Ossola P, Rossi R, Jannini T, Caruso R, Nanni M, Grassi L. The association between cannabis use and paranoia: Meta-analysis of experimental and observational studies. Neuroscience & Biobehavioral Reviews 2025, 176: 106269. PMID: 40578496, DOI: 10.1016/j.neubiorev.2025.106269.Peer-Reviewed Original ResearchConceptsParanoid symptomsCannabis useBayesian model-averaged meta-analysisStandardized mean differencePsychiatric disordersEffect size measuresObservational studyBayesian meta-analysesMeta-analysisOdds ratioCannabinoid useCannabinoid usersCannabinoidParanoiaCannabisTherapeutic actionCross-sectional studyBayesian meta-analysisSymptomsPooled effectMeta-analysesGeneral populationMean differenceNon-usersProspective studyPsychiatric Hospitalization After Enrollment in Coordinated Specialty Care: Unexpected Gender- and Age-Related Disparities
Vohs J, Tayfur S, Li F, Song Z, Breitborde N, Cahill J, Chaudhry S, Ferrara M, Heckers S, Satchivi A, Silverstein S, Taylor S, Tso I, Weiss A, Breier A, Srihari V. Psychiatric Hospitalization After Enrollment in Coordinated Specialty Care: Unexpected Gender- and Age-Related Disparities. Schizophrenia Bulletin 2025, 52: sbaf260. PMID: 41863376, PMCID: PMC13005094, DOI: 10.1093/schbul/sbaf260.Peer-Reviewed Original ResearchConceptsLength of stayLonger length of stayFirst-episode psychosisEarly Psychosis Intervention NetworkCoordinated Specialty CareEarly psychosis careAge-related disparitiesBlack/African American participantsNegative binomial regressionPsychosis careIntervention NetworkSpecialty careMultidisciplinary interventionWhite participantsHospitalization ratesPsychiatric hospitalBinomial regressionHospital outcomesElevated riskFunctional declineFrequent admissionsPrimary outcomeHospitalization frequencyHealthcare burdenFrequent hospitalizationsEnhancing Coordinated Specialty Care Through Early Detection: Impact of Reduced Duration of Untreated Psychosis
Hazan H, Ferrara M, Zhou B, Li F, Imetovski S, Sykes L, Pollard J, Cahill J, Gibbs-Dean T, Corbera S, Karmani S, Riley S, Tayfur S, Tek C, Keshavan M, Srihari V. Enhancing Coordinated Specialty Care Through Early Detection: Impact of Reduced Duration of Untreated Psychosis. Schizophrenia Bulletin 2025, 51: 1730-1737. PMID: 40339151, PMCID: PMC12597490, DOI: 10.1093/schbul/sbaf044.Peer-Reviewed Original ResearchDuration of untreated psychosisFirst-episode psychosisCoordinated Specialty CareUntreated psychosisMediation analysisShorter duration of untreated psychosisFirst-episode psychosis patientsEarly interventionEarly psychosisBenefits of early interventionPsychosisGAFFunctional outcomesGlobal assessmentEarly detection campaignsSpecialty careIntake processRecovery outcomesSpecial treatmentQuality of lifeStreamlining referralsFunctional recoveryScoresPatientsInterventionSex-Specific Treatment Strategies in First Episode Psychosis
Ferrara M, Srihari V. Sex-Specific Treatment Strategies in First Episode Psychosis. Biological Psychiatry 2025, 97: s53. DOI: 10.1016/j.biopsych.2025.02.144.Peer-Reviewed Original ResearchComparative Effectiveness of Long-Acting Injectable Vs. Oral Antipsychotic Medication After a First Episode of Psychosis: A Target Trial Emulation
Szmulewicz A, Martínez-Alés G, Ferrara M, Fredrikson D, Díaz-Caneja C, Sarpal D, Shinn A, Arango C, Öngür D, Hernán M. Comparative Effectiveness of Long-Acting Injectable Vs. Oral Antipsychotic Medication After a First Episode of Psychosis: A Target Trial Emulation. Biological Psychiatry 2025, 97: s52-s53. DOI: 10.1016/j.biopsych.2025.02.142.Peer-Reviewed Original ResearchInsight and Its Trajectory: Predicting the Risk of Psychiatric Hospitalizations Among First-Episode Psychosis During the First Year of Coordinated Specialty Care
Hazan H, Ferrara M, Gibbs-Dean T, Tayfur S, Corbera S, Karmani S, Song Z, Li F, Vlachos I, Selakovic M, Tek C, Srihari V. Insight and Its Trajectory: Predicting the Risk of Psychiatric Hospitalizations Among First-Episode Psychosis During the First Year of Coordinated Specialty Care. Schizophrenia Bulletin 2025, 52: sbaf019. PMID: 40227145, PMCID: PMC12809808, DOI: 10.1093/schbul/sbaf019.Peer-Reviewed Original ResearchCoordinated Specialty CareFirst-episode psychosisBaseline insightRisk of psychiatric hospitalizationFirst-episodeEarly psychosisInsight groupLength of stayPsychiatric hospitalSpecialty carePsychosisLongitudinal trajectoriesGreater reductionsHospital outcomesHigh-low-highPredicting clinical improvementHospital dataModifiable factorsMonths pre-ParticipantsHospitalization riskClinical improvementRecovery trajectoriesReduce hospitalizationsBaselineComparative effectiveness of long-acting injectable versus oral antipsychotic medication after a first episode of psychosis
Szmulewicz A, Martínez-Alés G, Logan R, Joober R, Ferrara M, Kelly C, Fredrikson D, Thorpe L, Conderino S, Díaz-Caneja C, Srihari V, Yatham L, Sarpal D, Shinn A, Arango C, Shah J, Öngür D, Hernán M. Comparative effectiveness of long-acting injectable versus oral antipsychotic medication after a first episode of psychosis. Nature Mental Health 2025, 3: 421-428. DOI: 10.1038/s44220-025-00407-5.Peer-Reviewed Original ResearchEpisode of psychosisPsychotic relapseLong-actingTarget trialsRisk of psychotic relapseLong-acting antipsychoticsOral antipsychotic medicationEffects of long-actingLAI therapyAntipsychotic therapyAntipsychotic medicationSchizophrenia trialsTherapy initiationRisk of relapseOral therapyPsychosisRisk differenceFEPObservational cohort of peopleHospitalization riskCohort of peopleNetwork meta-analysesNo risk reductionNon-adherenceRelapse